Improving Deep Learning-Based Target Volume Auto-Delineation for Adaptive MR-Guided Radiotherapy in Head and Neck Cancer: Impact of a Volume-Aware Dice Loss

📅 2026-04-11
📈 Citations: 0
Influential: 0
📄 PDF

career value

187K/year
🤖 AI Summary
This study addresses the challenges of time-consuming manual delineation and frequent omission of small-volume metastatic lymph nodes in head and neck cancer radiotherapy. To overcome these limitations, the authors propose a volume-aware Dice loss function integrated with selective and dual-mask strategies within an nnU-Net ResEnc M architecture for multi-label automatic segmentation of primary tumors and metastatic lymph nodes. By incorporating volume-sensitive weighting, the method enhances detection sensitivity for small lesions. Evaluated on the HNTS-MRG 2024 dataset, the dual-mask approach achieves a lymph node detection sensitivity of 83.46% while maintaining a primary tumor segmentation Dice score of 82.04%. In contrast, the selective strategy improves the lymph node Dice coefficient to 0.758 but at the cost of reduced primary tumor segmentation accuracy.

Technology Category

Application Category

📝 Abstract
Background: Manual delineation of target volumes in head and neck cancer (HNC) remains a significant bottleneck in radiotherapy planning, characterized by high inter-observer variability and time consumption. This study evaluates the integration of a Volume-Aware (VA) Dice loss function into a self-configuring deep learning framework to enhance the auto-segmentation of primary tumors (PT) and metastatic lymph nodes (LN) for adaptive MR-guided radiotherapy. We investigate how volume-sensitive weighting affects the detection of small, anatomically complex nodal metastases compared to conventional loss functions. Methods: Utilizing the HNTS-MRG 2024 dataset, we implemented an nnU-Net ResEnc M architecture. We conducted a multi-label segmentation task, comparing a standard Dice loss baseline against two Volume-Aware configurations: a "Dual Mask" setup (VA loss on both PT and LN) and a "Selective LN Mask" setup (VA loss on LN only). Evaluation metrics included volumetric Dice scores, surface-based metrics (SDS, MSD, HD95), and lesion-wise binary detection sensitivity and precision. Results: The Selective LN Mask configuration achieved the highest LN Volumetric Dice Score (0.758 vs. 0.734 baseline) and significantly improved LN Lesion-Wise Detection Sensitivity (84.93% vs. 81.80%). However, a critical trade-off was observed; PT detection precision declined significantly in the selective setup (63.65% vs. 81.27%). The Dual Mask configuration provided the most balanced performance across both targets, maintaining primary tumor precision at 82.04% while improving LN sensitivity to 83.46%. Conclusions: A volume-sensitive loss function mitigated the under-representation of small metastatic lesions in HNC. While selective weighting yielded the best nodal detection, a dual-mask approach is required in multi-label tasks to maintain segmentation accuracy for larger primary tumor volumes.
Problem

Research questions and friction points this paper is trying to address.

target volume auto-delineation
head and neck cancer
metastatic lymph nodes
adaptive MR-guided radiotherapy
inter-observer variability
Innovation

Methods, ideas, or system contributions that make the work stand out.

Volume-Aware Dice Loss
Auto-segmentation
Adaptive MR-guided Radiotherapy
Head and Neck Cancer
nnU-Net
🔎 Similar Papers
S
Sogand Beirami
Strahlenklinik, Universitätsklinikum Erlangen, Germany
Z
Zahra Esmaeilzadeh
Strahlenklinik, Universitätsklinikum Erlangen, Germany
Ahmed Gomaa
Ahmed Gomaa
PhD Candidate
medical imagingradiation oncologydeep learningsurvival analysis
P
Pluvio Stephan
Strahlenklinik, Universitätsklinikum Erlangen, Germany
I
Ishita Sheth
Strahlenklinik, Universitätsklinikum Erlangen, Germany
T
Thomas Weissmann
Strahlenklinik, Universitätsklinikum Erlangen, Germany
J
Juliane Szkitsak
Strahlenklinik, Universitätsklinikum Erlangen, Germany
P
Philipp Schubert
Strahlenklinik, Universitätsklinikum Erlangen, Germany
Y
Yixing Huang
Strahlenklinik, Universitätsklinikum Erlangen, Germany
A
Annette Schwarz
Strahlenklinik, Universitätsklinikum Erlangen, Germany
S
Stefanie Corradini
Strahlenklinik, Universitätsklinikum Erlangen, Germany
F
Florian Putz
Strahlenklinik, Universitätsklinikum Erlangen, Germany